Added to YB: 2024-04-12
Pitch date: 2024-04-09
INSM [bullish]
Insmed Incorporated
+163.68%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
Market Cap
$11.7B
Pitch Price
$27.59
Price Target
N/A
Dividend
N/A
Sector
Biotechnology
Category
growth
Show full summary:
ClearBridge Small Cap Growth Strategy New Position: Insmed Incorporated
INSM: Biopharma focused on rare lung diseases. Approved product growing domestically & internationally w/ label expansion potential. Late-stage pipeline w/ blockbuster sales potential.
Read full article (1 min)